Research
Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2549 (Published 10 May 2011) Cite this as: BMJ 2011;342:d2549
Related articles
- Editorial Published: 10 May 2011; BMJ 342 doi:10.1136/bmj.d2655
- Research Article Published: 14 February 1981; Br Med J (Clin Res Ed) 282 doi:10.1136/bmj.282.6263.548
- Correspondence Published: 29 June 1901; Br Med J 1 doi:10.1136/bmj.1.2113.1645
- Research Published: 22 November 2013; BMJ 347 doi:10.1136/bmj.f6650
See more
- A lump in the throat: laryngopharyngeal refluxBMJ November 02, 2020, 371 m4091; DOI: https://doi.org/10.1136/bmj.m4091
- Investigating coeliac disease in adultsBMJ June 17, 2020, 369 m2176; DOI: https://doi.org/10.1136/bmj.m2176
- Recurrent vulvovaginal candidiasisBMJ June 08, 2020, 369 m1995; DOI: https://doi.org/10.1136/bmj.m1995
- Pernicious anaemiaBMJ April 24, 2020, 369 m1319; DOI: https://doi.org/10.1136/bmj.m1319
- Blurred visionBMJ March 04, 2020, 368 m569; DOI: https://doi.org/10.1136/bmj.m569
Cited by...
- Course of DISease In patients reported to the Swedish CPAP Oxygen and VEntilator RegistrY (DISCOVERY) with population-based controls
- Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study
- Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease
- Cardiovascular disease and COPD: dangerous liaisons?
- The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis
- Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
- Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease
- Effect of {beta}-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD
- Evidence of potential bias in a comparison of {beta} blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study
- Underuse of {beta}-blockers in heart failure and chronic obstructive pulmonary disease
- Beta-blockers in COPD: time for reappraisal
- {beta}-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease ({beta}LOCK COPD): a randomised controlled study protocol
- {beta}-Blockers are associated with a reduction in COPD exacerbations
- {beta}-Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
- Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up
- Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
- Effects of intravenous and oral {beta}-blockade in persistent asthmatics controlled on inhaled corticosteroids
- Effect of {beta} blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records
- Resting heart rate is a predictor of mortality in COPD
- {beta}-Blockers for COPD inpatients
- Pharmacology and Therapeutics of Bronchodilators
- Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD
- Thorax in focus: chronic obstructive pulmonary disease
- {beta}-blockers associated with reduced all-cause mortality in COPD
- Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis
- {beta}-Blockers in COPD Patients
- Treatment with {beta} blockers in people with COPD